Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
What have we learned from a de...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
What have we learned from a decade of patient involvement in OMERACT and its effect on trial outcome assessments?
Bibliographic Details
Main Authors:
Kirwan John R
,
de Wit Maarten
Format:
Article
Language:
English
Published:
BMC
2011-12-01
Series:
Trials
Holdings
Description
Similar Items
Staff View
Description
ISSN:
1745-6215
Similar Items
Clinical trial outcomes for SLE: what we have and what we need
by: Laurent Arnaud, et al.
Published: (2024-05-01)
Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews
by: Rikke A. Andreasen, et al.
Published: (2020-07-01)
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
by: Merkel, P, et al.
Published: (2011)
Five decades of Fontan palliation: What have we learned? What should we expect?
by: Adil Hassan, et al.
Published: (2023-10-01)
The Omeract-Oarsi core set of outcome domains to measure in clinical trials for people with hip and/or knee osteoarthritis
by: Smith, T, et al.
Published: (2018)